Cargando…
The combination therapy of isomucronulatol 7-O-beta-glucoside (IMG) and CEP-9722 targeting ferroptosis-related biomarkers in non-small cell lung cancer (NSCLC)
BACKGROUND: NSCLC is a malignant tumor with a high incidence. Ferroptosis presents an essential function in regulating carcinogenesis and tumor progression. However, the ferroptosis-associated prognostic model based on single-cell sequencing of NSCLC remains unexplored. Our study aims to establish a...
Autores principales: | Cui, Xiaofei, Liu, Chang, Dong, Penghua, Liu, Chao, Bai, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173508/ https://www.ncbi.nlm.nih.gov/pubmed/37165402 http://dx.doi.org/10.1186/s12890-023-02445-0 |
Ejemplares similares
-
Phase 1 dose-escalation study of the PARP inhibitor CEP-9722 as monotherapy or in combination with temozolomide in patients with solid tumors
por: Plummer, Ruth, et al.
Publicado: (2014) -
Inhibition of Osteoarthritis-Related Molecules by Isomucronulatol 7-O-β-d-glucoside and Ecliptasaponin A in IL-1β-Stimulated Chondrosarcoma Cell Model
por: Hong, Gwan Ui, et al.
Publicado: (2018) -
The integrated microbial genomes (IMG) system
por: Markowitz, Victor M., et al.
Publicado: (2006) -
Preparation of IMGs for Residency Training in Canada
por: Duncan, Andrew, et al.
Publicado: (2012) -
Back Numbers of the I.M.G.
por: Ball, J. Donald
Publicado: (1947)